Medindia LOGIN REGISTER
Medindia
Multisystem Inflammatory Syndrome (MIS-C)

FAQs on Multisystem Inflammatory Syndrome (MIS-C)

Q: Which specialist doctor to consult for Multisystem Inflammatory Syndrome?

A: A team of specialistsincluding experts in infectious disease, pediatrician, cardiologist, and rheumatologist can help to diagnose and treat Multisystem Inflammatory Syndrome.

Advertisement

Q: What is the inflammatory condition linked to COVID-19 in children?

A: Multisystem inflammatory syndrome in children (MIS-C) is a recently identified syndrome that appears to be temporally associated with novel COVID-19 infection.

Q: What are the complications of MIS-C?

A: In the absence of early diagnosis and appropriate treatment, MIS-C can lead to severe problems with vital organs, such as the heart, lungs or kidneys. In rare cases, MIS-C could result in permanent damage or even death.

Q: If my child has MSI-C, does that mean he or she had COVID-19?

A: Pediatric multisystem inflammatory syndrome (PMIS) is thought to result from the body’s immune response to coronavirus and is not a direct effect of an acute, active COVID-19 infection.

Most children with MSI-C have tested positive for COVID-19, and there is a strong connection between PMIS and COVID-19 in terms of timing and geographical association.

Q: Who is most at risk for PMIS?

A: More Black and Latino children have been diagnosed with MIS-C compared with children of other races and ethnic groups.

Children between the ages of 3 and 12 years old are commonly affected. Some cases have also occurred in older children and in infants.

Q: Can adults Get MIS?

A: Yes, but for them it's called MIS-A and can also be dangerous or deadly without medical care. Adults who get MIS usually need intensive care at the hospital, according to CDC reports.


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education